Cancer :: Claims for Green Tea and Certain Cancers

Under the Food and Drug Administration’s (FDA) “Consumer Health for Better Nutrition Initiative,” the Agency is announcing the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer. Based on a systematic evaluation of the available scientific data, the FDA intends to consider exercising its enforcement discretion for the following qualified health claims for breast and prostate cancer:

Joint Pain :: New Topical Therapy Brings Relief to Pain Sufferers

ALCiS Health Inc., a consumer health company specializing in pain relief and body therapy products that utilize unique drug delivery technologies, announced the availability of ALCiS Daily Relief, a topical pain cream engineered to provide fast relief from muscle and joint pain, including that associated with arthritis, backache, strains, sprains and bruises.

Nutrition :: Major Initiatives for Dietary Supplements

The Food and Drug Administration announced three major regulatory initiatives designed to further implement the Dietary Supplement Health and Education Act of 1994 (DSHEA). These initiatives — a regulatory strategy, an open public meeting, and a draft guidance document for industry — are significant steps FDA has taken in the implementation of DSHEA.